Download PDF
Dtsch Med Wochenschr 2013; 138(23): 1236-1239
DOI: 10.1055/s-0033-1343171
Rheumatologie | Commentary
Rheumatologie
© Georg Thieme Verlag KG Stuttgart · New York

Vaskulitis

Update 2013VasculitisUpdate 2013
M. Fleck
1   Klinik und Poliklinik für Innere Medizin I, Universitätsklinikum Regensburg, und Klinik für Rheumatologie/Klinische Immunologie, Asklepios Klinikum Bad Abbach
,
B. Hellmich
2   Klinik für Innere Medizin Kreiskliniken Esslingen gGmbH, Klinik Kirchheim
› Author Affiliations
Further Information

Publication History

Publication Date:
29 May 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Vaskulitis - Chapel-Hill-Nomenklatur - Rituximab - CT-Angiographie

Keywords

vasculitis - Chapel-Hill nomenclature - rituximab - CT angiography
 

  • Literatur

  • 1 Cartin-Ceba R, Golbin JM, Koegh KA et al. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener’s): ten year experience at a single center. Arthritis Rheum 2012; 64: 3770-3778
    CrossrefPubMedGoogle Scholar
  • 2 Falk RJ, Gross WL, Guillevin L et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis 2011; 70 (04) 704
    CrossrefPubMedGoogle Scholar
  • 3 Grayson PC, Maksimowicz-McKinnon K, Clark TM et al. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis 2012; 71: 1329-1334
    CrossrefPubMedGoogle Scholar
  • 4 Hellmich B, Fleck M. Vaskulitis. Update 2012. Dtsch Med Wochenschr 2012; 137: 1188-1191
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Jennette J, Falk R, Bacon P et al. Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2012; Oct 8. doi: DOI: 10.1002/art.37715. [Epub ahead of print]
    PubMedGoogle Scholar
  • 6 Kermani TA, Warrington KJ, Crowson CS et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2012; Dec 19. [Epub ahead of print]
    PubMedGoogle Scholar
  • 7 Lyons PA, Rayner TF, Trivedi S et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367: 214-223
    CrossrefPubMedGoogle Scholar
  • 8 Mahr A, Katsahian S, Varet H et al. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmatic antibody-assocaited vasculitis: a cluster analysis. Ann Rheum Dis 2012; Dec 12 [epub ahead of print]
    PubMedGoogle Scholar
  • 9 Martin-Garrido I, Carmona EM, Specks U et al. Pneumocystis pneumonia in patients treated with rituximab. Chest 2012; Dec 20. doi: DOI: 10.1378/chest.12-0477. (Epub ahead of print)
    PubMedGoogle Scholar
  • 10 Prieto-González S, Arguis P, García-Martínez A et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012; 71: 1170-1176
    CrossrefPubMedGoogle Scholar
  • 11 Smith RM, Jones RB, Guerry MJ et al. Rituximab for maintenance of remission in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012; 64: 3760-3769
    CrossrefPubMedGoogle Scholar
  • 12 Unizony S, Arias-Urdaneta L, Miloslavsky E et al. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res 2012; 64: 1720-1729
    PubMedGoogle Scholar